Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Financials
Overview
ProteinQure is a Toronto biotechnology company founded in 2017 that designs peptide therapeutics computationally. Its platform combines molecular simulation with machine learning to engineer targeted cancer drugs. The company runs its own programmes alongside pharmaceutical partnerships.
News
The Monomers We Can't Find: Building a Map of Non-Canonical Chemical Space
You Can Buy It. Can You Find It? Written by Julie Owen, ProteinQure This is semaglutide. The peptide drug that has transformed obesity treatment by copying a naturally occurring gut hormone. Its clinical success rests on a few edits to the natural sequenc
Read more
Report
ProteinQure Receives $1.8M from FedDev Ontario to Advance AI-Powered Drug Delivery
TORONTO, Ontario, May 27, 2026 - ProteinQure Inc., a clinical-stage biotechnology company leveraging machine learning and generative AI to design precision therapeutics, announced it has received $1.8 million in funding from the Government of Canada throu
Read more
Report
ProteinQure Receives $2.5M Genome Canada Award to Advance siRNA Therapeutics for Glioblastoma
The company also appoints world-renowned neuro-oncologists Dr. Henry S. Friedman and Dr. Alexandra M. Miller to Clinical Advisory Board. TORONTO, Ontario, April 7, 2026 - ProteinQure Inc., a clinical-stage biotechnology company leveraging machine learning
Read more
Report
ProteinQure Reports Broad Brain Distribution of Peptide-siRNA Conjugates in Non-Human Primates
TORONTO, Ontario, October 15, 2025 - ProteinQure announced new preclinical results today, demonstrating efficient delivery of small interfering RNA (siRNA) to the central nervous system (CNS) in non-human primates. Using intrathecal administration of prop
Read more
Report
ProteinQure Announces First Patient Dosed in Phase I Clinical Trial of PQ203 in Advanced Metastatic Cancer
TORONTO, Ontario, September 17, 2025 - ProteinQure Inc., a Toronto-based biotech company pioneering computational peptide drug discovery, today announced the successful dosing of the first patient in its Phase I clinical trial evaluating PQ203 - a novel,
Read more
Report
Pro access
Upgrade to see all 25 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Toronto
Canada
HQ
ProteinQure Headquarters
108 College St, Suite 580, , Toronto, ON M5G 0C6 Canada